Left ventricular hypertrophy in the elderly

American Journal of Geriatric Cardiology

Volumn 6, Issue 6, 1997, Pages 38-49

  Ghali, Jalal K ^a   Liao, Youlian ^b   Cooper, Richard S ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CONFERENCE PAPER; DEATH; DISEASE PREDISPOSITION; EXERCISE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; PREVALENCE; RISK ASSESSMENT; RISK MANAGEMENT; SODIUM RESTRICTION; STROKE; WEIGHT REDUCTION;

EID: 0030663313     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (95)

1. National Center for Health Statistics: Advance report of final mortality statistics, 1988. Monthly Statistics Report. Hyattsville, Maryland: Public Health Service, 1990;39:7(suppl) 1-48.
2. Wenger NK. Inclusion of elderly individuals in clinical trials: Cardiovascular disease and cardiovascular therapy as a model. Workshop at the American College of Cardiology, September 1992. Marion Merrill Dow, Inc. 1993.
3. Bove KE, Rowland DT, Scott RC. Observations on the assessment of cardiac hypertrophy using a chamber partition technique. Circulation. 1966;33:558-568.
4. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618.
5. Devereux RB, Alonso DR, Lutas E, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1996;57:450-458.
6. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222-1230.
7. Savage DD, Garrison RJ, Kannel WB, et al. The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 1987;75(suppl I):1-26-1-33.
8. Levy D, Savage DD, Garrison RJ, et al. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Study. Am J Cardiol. 1987;59:956-960.
9. Liao Y, Cooper RS, Duraxo-Arvizu R, et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol. 1997;29(3):641-647.
10. Hammond IW, Devereux RB, Alderman MH, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986;7:639-650.
11. Shapiro LM, Mackinnon J, Beevers DG. Echocardiographic features of malignant hypertension. Br Heart J 1981;46:374-379.
12. Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Intern Med. 1988;108: 7-13.
13. Psaty BM, Furberg CD, Kuller LH, et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly: Initial findings from the Cardiovascular Health Study. JAMA. 1992;268: 1287-91.
14. Tuzcu EM, Golz SJ, Lever HM, et al. Left ventricular hypertrophy in persons age 90 years and older. Am J Cardiol. 1989;63:237-240.
15. Pearson AC, Gudipati C, Nagelhout D, et al. Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol. 1991;17:2:422-430.
16. Prisant LM, Carr AA. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and man. Am J Hypertens. 1990;3:81-89.
17. Dryer JIM, Weber MA, deJong JL. Blood pressure as a determinant of cardiac left ventricular muscle mass. Arch Intern Med. 1983;143:90-92.
18. Ren J-F, Hakki A-H, Kotler MN, et al. Exercise systolic blood pressure: A powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiol. 1985;5:1224-1231.
19. Devereux RB, Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure responses to regularly recurring stress. Circulation. 1983;68:470-476.
20. Gerstenblith G, Fredericksen J, Yin FCP, et al. Echocardiographic assessment of a normal adult aging population. Circulation. 1977;56:273-278.
21. Lindroos M, Kupari M, Heikkila J, et al. Echocardiographic evidence of left ventricular hypertrophy in a general aged population. Am J Cardiol. 1994;74:385-390.
22. Grandi AM, Venco A, Barzizza F, et al. Influence of age and sex on left ventricular anatomy and function in normals. Cardiology. 1992;81:8-13.
23. Howell TH. Heart weights among octogenarians. J Am Geriatr Soc. 1981;9:572-575.
24. Kitzman DW, Scholz DG, Hagen PT, et al. Age-related changes in normal human hearts during the first 10 decades of life, part II: Maturity-quantative anatomic study of 765 specimen from subjects 20 to 99 years old. Mayo Clin Proc. 1988;63:137-146.
25. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol. 1989;64:1066-1068.
26. Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombolic brain infarction in patients over 62 years of age. Am J Cardiol. 1988;61:1130-1132.
27. Gottdiener JS, Reda DJ, Materson BJ, et al, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 1994;24(6):1492-1498.
28. Lauer MS, Anderson KM, Kannel WB, et al. Separate and joint influences of obesity and mild hypertension of left ventricular mass and geometry: The Framingham Heart Study. J Am Coll Cardiol. 1992;19:130-134.
29. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program: prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension. 1985;7:105-112.
30. Lee DK, Marantz PR, Devereux RB, et al. Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence. JAMA. 1992;267:3294-3299.
31. Chaturvedi N, Athanassopoulos G, McKeigue P, et al. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol. 1994;24:1499-505.
32. Aronow WS, Kronzon I. Prevalence of coronary risk factors in elderly blacks and whites. J Am Geriatr Soc. 1991;39:567-570.
33. Ferrara LA, de Simone G, Pasanisi F, et al. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension. 1984;6:755-759.
34. Beil AH, Schmieder RE. Salt intake as a determinant of cardiac hypertrophy. Blood Pressure. 1995;4(suppl 2):30-34.
35. Devereux RB, Drayer JIM, Chien S, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol. 1984;54:592-595.
36. Sava PS, Roman MJ, Pini R, et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22(71):873-880.
37. Manolio TA, Levy D, Garrison RJ, et al. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol. 1991;17(3):717-21.
38. Morgan HE, Baker KM. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
39. Radice M, Alli C, Avanzini F, et al. Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J. 1996;111(1):115-120.
40. Harshfield GA, Grim CE, Hwang C, et al. Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins. J Hypertens. 1990;3:538-543.
41. Iwai N, Ohmichi N, Nakamura Y, et al. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90(6):2622-2628.
42. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19(7):1550-1558.
43. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: Relation to left ventricular mass and systolic function. J Am Coll Cardiol. 1984;3(6): 1500-1506.
44. Sagie A, Benjamin EJ, Galderisi M, et al. Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study). Am J Cardiol. 1993;72:662-665.
45. Inouye I, Massie B, Loge D, et al. Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984;53:120-126.
46. Fouad FM, Tarazi RC, Gallagher JH, et al. Abnormal left ventricular relaxation in hypertensive patients. Clin Sci. 1980;59(suppl 6):411s-414s.
47. Miytake K, Okamoto J, Kimoshita N, et al. Augmentation of atrial contribution to left ventricular flow with aging as assessed by intracardiac Doppler flowmetry. Am J Cardiol. 1984;53:587-589.
48. Swinne CJ, Shapiro EP, Lima SD, et al. Age-associated changes in left ventricular diastolic performance during isometric exercise in normal subjects. Am J Cardiol. 1991;69:823-826.
49. Bonow RO, Bacharach SL, Green MV, et al. Impaired left ventricular diastolic filling in patients with coronary artery disease with radionuclide angiography. Circulation. 1981;64:315-323.
50. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: Cardiac dilation and increased stroke volume compensate for diminished heart rate. Circulation. 1984;69:203-213.
51. Pringle SD, MacFarlane PW, McKillop JH, et al. Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol. 1993;13:1377-1381.
52. Aronow WS, Epstein S, Koenigsberg M. Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease. Angiology. 1990;41:189-193.
53. Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90-105 years old. Mayo Clin Proc. 1988;63:552-564.
54. Lorell BH, Wexler LF, Momomura S, et al. The influence of pressure overload hypertrophy on diastolic properties during hypoxia in isovolumically contracting rat hearts. Circ Res. 1986;58:653-663.
55. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol. 1979;44:999-1006.
56. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation. 1984;69:1-7.
57. Pichard AD, Gorlin R, Smith H, et al. Coronary flow studies in patients with left ventricular hypertrophy of the hypertensive type: Evidence for an impaired coronary vascular reserve. Am J Cardiol. 1981;47:547-554.
58. Ozan JJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol. 1988;62:30G-35G.
59. Jalil JE, Doering CW, Janicki JS, et al. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rate left ventrad. Circ Res. 1989; 64:1041-1050.
60. Weber KT, Janicki JS, Shroff SG, et al. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988;62:757-765.
61. Tomanek RJ, Palmer PJ, Peiffer GL, et al. Morphometry of canine coronary arteries, arterioles and capillaries during hypertension and left ventricular hypertrophy. Circ Res. 1986;58:38-46.
62. Kaufmann P, Vassalli G, Lupi-Wagner S, et al. Coronary artery dimension in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol. 1996;28(3):745-750.
63. Panza JA, Casino PR, Kilcoyne CM, et al. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
64. Brush JE, Cannon RO, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 1988;319:1302-1307.
65. McLenachan JM, Henderson E, Morris Ml, et al. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987;317:87-92.
66. Ghali JK, Kadakia S, Cooper RS, et al. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol. 1991;17:1277-1282.
67. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality, risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 1993;22(4):1111-1116.
68. Aronow WS, Epstein S, Schwartz KS, et al. Correlation of complex ventricular arrhythmias detected by ambulatory electrocardiographic monitoring with echocardiographic left ventricular hypertrophy in persons older than 62 years in a long-term health care facility. Am J Cardiol. 1987;60:730-732.
69. Aronow WS, Epstein S, Koenigsberg M, et al. Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol. 1988;62:1124-1125.
70. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. JAMA. 1994;272(1):33-36.
71. Aronow WS, Ahn C, Kronzon I, et al. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol. 1991;67:295-299.
72. Kannel WB, Castelli WP, McNamara PM, et al. Role of blood pressure in the development of congestive heart failure: The Framingham Study. N Engl J Med. 1972;287:781-787.
73. Lorell BH, Grossman W. Cardiac hypertrophy: The consequences for diastole. J Am Coll Cardiol. 1987;9:1189-1193.
74. Swynghedauw B, Schwartz K, Apstein CS. Decreased contractility after myocardial hypertrophy: Cardiac failure or successful adaptation? Am J Cardiol. 1984;54:437-440.
75. Blake J, Devereux RB, Borer JS, et al. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy of left ventricular exercise dysfunction in essential hypertension. Am J Med. 1990;88:477-485.
76. Kannel WB. Hypertension in the elderly: Epidemiologic appraisal from the Framingham Study. Cardiol Elderly. 1993;1:356-363.
77. Levy D, Garrison RJ, Savage D, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: The Framingham Heart Study. Ann Intern Med. 1989;110:101-107.
78. Dellsperger KC, Clothier JL, Hartnett JA, et al. Acceleration of the wavefront of myocardial necrosis by chronic hypertension and left ventricular hypertrophy in dogs. Circ Res. 1988;63:87-96.
79. Koyanagi S, Eastham CL, Harrison DG, et al. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res. 1982;50:55-62.
80. Koyanagi S, Eastham CL, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation. 1982;65:1192-1197.
81. Bolognese L, Della vesa P, Rossi L, et al. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol. 1994;73:1-5
82. Boden WE, Kleiger RE, Schechtman KB, et al, and the Diltiazem Reinfarction Study Research Group. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. Am J Cardiol. 1988;62:1000-1004.
83. Kannel WB, Sorlie P. Left Ventricular hypertrophy in hypertension: prognostic and pathogenetic implication. The Framingham Study. In: Strauer BE (ed) The Heart in Hypertension. New York: Springer-Verlag; 1981;223-242.
84. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173-178.
85. Levy D, Garrison GJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
86. Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 1991;117(10):831-836.
87. Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995;273:1592-1597.
88. McMahon SW, Wilcken DE, MacDonald GJ. The effects of weight reduction on left ventricular mass. A randomized controlled trial in your over-weight hypertensive patients. N Engl J Med. 1986;314:334-339.
89. Colan SD, Sanders SP, Borow KM. Physiologic hypertrophy: Effects on left ventricular systolic mechanics in athletes. J Am Coll Cardiol. 1987;9:776-783.
90. Maron BJ, Roberts WC, McAllister HA, et al. Sudden death in young athletes. Circulation. 1980;62:218-229.
91. Kokkinos PF, Narayan P. Colleran JA, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med. 1995;333:1462-1467.
92. Granger CB, Karimeddini MK, Smith VE, et al. Rapid ventricular filling in left ventricular hypertrophy. I. Physiologic hypertrophy. J Am Coll Cardiol. 1985;5:862-868.
93. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. JAMA. 1993;270:713-724.
94. Schmieder RE, Martus P, Klingbell A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996;275(19):1507-1513.
95. Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 1990;322:1350-1356.